Scientific Research
At OSR Holdings, we are committed to advancing transformative therapies grounded in rigorous scientific research. Below are selected publications and conference abstracts that provide scientific context for our programs and the underlying biology of our pipeline candidates.
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade